Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: Role of duration of atrial fibrillation

Raine, 1986, Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure, N Engl J Med, 315, 533, 10.1056/NEJM198608283150901 Trovato, 1994, Effects of atrial fibrillation on the increase of atrial natriuretic peptide in congestive heart failure, Recenti Prog Med, 85, 570 Davies, 1972, Pathology of atrial fibrillation in man, Br Heart J, 34, 520, 10.1136/hrt.34.5.520 Sanfillippo, 1990, Atrial enlargement as a consequence of atrial fibrillation: a prospective echocardiographic study, Circulation, 82, 792, 10.1161/01.CIR.82.3.792 Seino, 1991, Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence, J Am Coll Cardiol, 18, 459, 10.1016/0735-1097(91)90601-5 Van Den Berg, 1995, Effects of lisinopril in patients with heart failure and chronic atrial fibrillation, J Card Failure, 1, 355, 10.1016/S1071-9164(05)80004-1 Ambler, 1994, Regulation of atrial natriuretic peptide secretion by α1-adrenergic receptors: the role of the second messenger pathways, J Mol Cell Cardiol, 26, 391, 10.1006/jmcc.1994.1048